Emory Healthcare Network Advantage

EHN Advantage Leadership

Key ACO Clinical and Administrative Leadership

ACO Executive: S. Patrick Hammond
Medical Director: Joel Shu, MD
Compliance Officer: Darcelle Skeete Burgess
Quality Assurance/Improvement Officer: Joel Shu, MD

Associated Committees and Committee Leadership

Committee Name: Medical Directors Committee
Committee Leader: Joel Shu, MD, Medical Director

Types of ACO Participants, or Combinations of Participants, that Formed the ACO:

ACO professionals in a group practice arrangement.

---

EMORY HEALTHCARE NETWORK ADVANTAGE IS A PARTICIPANT IN THE MEDICARE SHARED SAVINGS PROGRAM AS AN ACCOUNTABLE CARE ORGANIZATION.

Shared Savings and Losses

Amount of Shared Savings/Losses:

First Agreement Period

• Performance Year 2020, $6,918,488.93
  
  

Shared Savings Distribution:

First Agreement Period

• Performance Year 2020
  • Proportion invested in infrastructure: 33%
  • Proportion invested in redesigned care processes/resources: 33%
  • Proportion of distribution to ACO participants: 34%

Quality Performance Results

2020 Quality Performance Results

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for reporting, given the impact of the coronavirus disease 2019 (Covid-19) public health emergency (PHE) on these measures. 

Payment Rule Waivers 

Waiver for Payment for Telehealth Services

• Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.